Your email has been successfully added to our mailing list.

×
0.0188770571151985 0.0188770571151985 0.0188770571151985 0.0188770571151985 0.0188770571151985 0.0188770571151985 0.0188770571151985 0.0188770571151985
Stock impact report

FDA Ad Com renders split vote on Akcea's volanesoren [Seeking Alpha]

AKCEA THERAPEUTICS (AKCA) 
Last akcea therapeutics earnings: 2/25 04:05 pm Check Earnings Report
Company Research Source: Seeking Alpha
FDA Ad Com renders split vote on Akcea's volanesorenThe FDA's Endocrinologic and Metabolic Drugs Advisory Committee voted 12 - 8 that Akcea Therapeutics' (NASDAQ:AKCA) volanesoren should be approved in the U.S.Related ticker: (NASDAQ:IONS)Previously:Ionis and Akcea halted pending outcome of Ad Com vote on volanesoren (May 10)Previously:FDA Ad Com Thursday for Akcea's volanesoren(May 8)See all stocks on the move »Now read:Opko adds to Q1 results-stoked rally, up 3% » Show less Read more
Impact Snapshot
Event Time:
AKCA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for AKCA alerts
Opt-in for
AKCA alerts

from News Quantified
Opt-in for
AKCA alerts

from News Quantified